Daraprim, Tabletten

7680209640011 CH-20964 Tabletten

Associated product:

DARAPRIM cpr 25 mg 30 pce
Daraprim, Tabletten
Daraprim, Tabletten
Daraprim, Tabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
90.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.0006 MG Substance HBESI

Reimbursement information

Public price
CHF 31.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1962

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
20964
Drug name
Daraprim, Tabletten
Galenic form
TAB
ATC Code
P01BD01
Authorization status
Z
Dispensing category
B
First authorization
22/02/1955
Authorization expiration date
31/12/9999
IT Number
08.04.3.
Domain
Human medicine
Field of application
Toxoplasmose

Package details

Description (FR)
DARAPRIM cpr 25 mg 30 pce
Description (DE)
DARAPRIM Tabl 25 mg 30 Stk
Market launch
22/02/1955
Narcotic (BTM)
No

Other package sizes (1)

DARAPRIM cpr 25 mg blist 30 pce
None None
GTIN: 7680209640141
Not in V1